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Ischemic stroke is the leading cause of long-term neurolog-ical disability.1 Multifactorial cell death pathways triggered 
by cerebral ischemia lead to brain cell death and destruction of 
a large mass of brain tissue.2 This infarcted tissue, enclosed by 
the otherwise functional brain, acts as a reservoir for various 
cytotoxic and proinflammatory molecules that harm the adja-
cent healthy tissue, leading to augmented acute damage and 
secondary injury. In addition to adverse biochemical effects, 
the infarcted tissue forms a biological and physical barrier 
hampering neural reorganization, repair, and ultimately neu-
rological recovery. Thus, to enable effective recovery, cellular 
debris and dead cells need to be cleared from the stroke-
injured brain through a process involving phagocytosis. 
Microglia and infiltrating blood-derived macrophages (mi-
croglia/macrophages, MΦ) are the main phagocytes involved 
in this process, thus their proper function is fundamental to 
poststroke recovery.
For MΦ to engage in phagocytosis, they are regulated by 
various external (eg, cytokines, damage-associated molecular 
patterns) and internal (eg, PPAR [peroxisome proliferator-acti-
vated receptor]-γ; Nrf2 [nuclear factor erythroid-related fac-
tor 2], and scavenger receptors) factors provided by the local 
environment (eg, tissue injury) or pharmacological agents 
affecting these pathways.3–8 Prophagocytic MΦ are associated 
with anti-inflammatory and trophic phenotype, which is often 
referred to as the reparative phenotype that plays a beneficial 
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role in tissue repair.9–13 Recent studies demonstrated that soon 
after ischemic injury, the reparative MΦ phenotype is tran-
siently enhanced, in part, through release of IL (interleukin)-4 
by the ischemia-primed neurons.4 However, over time the 
abundance of the reparative MΦ declines, while the preva-
lence of proinflammatory, potentially harmful MΦ phenotype 
sharply increases.4,14,15 The balance between the numbers of 
reparative versus harmful MΦ could play an instrumental role 
in phagocytosis-mediated cleanup and poststroke recovery.
RXR (Retinoid X receptor) is a ligand-dependent, tran-
scription factor in the nuclear receptor superfamily.16 It 
regulates metabolism and immune responses, including in-
flammation resolution.8,17 The RXR-α isoform is uniquely 
abundant in macrophages, where it plays many essential 
functions, including tuning the expression of many genes as-
sociated with phagocytosis, including engulfment of myelin 
debris in a model of experimental autoimmune encephalomy-
elitis.7,8,17 PPAR-γ is a transcriptional partner of RXR. They 
form the heterodimer RXR:PPAR-γ18–20 that regulates target 
gene expression by binding to conserved DNA sequences, 
termed peroxisome-proliferator response elements. We and 
others have reported that the activation of PPAR-γ could po-
larize MΦ toward the reparative phenotype, with enhanced 
phagocytic function toward dead/damaged tissues and various 
cellular debris. This would lead to more efficient clearance of 
damage-associated cellular debris after ischemic stroke and 
intracerebral hemorrhage.3,4,21 Although PPAR-γ–selective 
ligands are sufficient for PPAR:RXR dimerization and bind-
ing to peroxisome proliferator response element (to activate 
transcription), RXR activation by its selective agonist may 
lead to homodimerization and formation of heterodimers with 
other nuclear receptors.8 Thus, RXR agonists could potently 
activate not only PPARγ22–25 but also other transcriptional pro-
cesses, for example, through liver x receptors,26 which could 
potentially improve MΦ functions in stroke-affected brain.
Here, we explored the role of RXR-α in MΦ as a factor in-
volved in regulating MΦ function in promoting brain tissue clear-
ance and neurological functional recovery after ischemic stroke.
Methods
The data that support the findings of this study are available from 
the corresponding author upon reasonable request. All animal studies 
followed the guidelines outlined in Guide for the Care and Use of 
Laboratory Animals from the National Institutes of Health and were 
approved by the Animal Welfare Committee of the UT-Health. All 
studies were performed using a randomization (coin toss) approach, 
and all the analyses were performed by investigators blinded to the 
treatment assignments (animals were coded for the group allocation). 
Animals were fed a standard rodent diet and housed in standard cages 
on a 12-hour inverted light-dark cycle. Experiments included male 
and female animals at ages of 4 to 6 months. Behavioral analyses 
were conducted from the hours of 10:00 am to 4:00 pm.
See the Materials in the online-only Data Supplement for detailed 
description of all the methods.
Mac-RXR-α−/− Mice
We used conditionally disrupted RXR-α mice in myeloid cells. 
The experimental mice were progeny of LyzM-Cre+/RXRα−/− mice 
crossed with RXR-αLoxP. The genotypes of mice were age- and sex-
matched littermates, either RXR-αLoxP wild-type control (LyzM-Cre−/
RXR-αLoxP) or Mac-RXR-α−/− knockout (LyzM-Cre+/RXR-αLoxP).27
Molecular Signaling and Genotyping
The sequence of polymerase chain reaction primers used to genotype 
LyzM-Cre mice are included in the supplement and follow earlier report.27
Administration of RXR Agonist
For in vitro experiments, microglia were preincubated for 24 hours 
with 0.5 μmol/L bexarotene (Sigma) and then exposed to dead neu-
rons (DN) to assess phagocytosis. Dimethyl sulfoxide (DMSO; 0.1%) 
was used for vehicle control. For in vivo studies, bexarotene in 3% 
DMSO was administered intraperitoneally at 5 mg/kg, first at 24 
hours after surgery and then once a day for a total of 7 days. DMSO 
(3%) was used for vehicle control.
Ischemia Model in Mice
Transient (60 minutes) focal ischemia was induced by unilateral 
middle cerebral artery (MCA)/common carotid artery occlusion 
(CCAo).4 We experienced no mortality.
Brain Atrophy Volume Measurement
The postischemic atrophy infarction volume was measured using in-
direct method as previously described.4
Neurological Deficits Measurement
Behavioral tests in mice were conducted in a quiet and low-lit room 
by an experimenter blinded with respect to the treatment groups. A 
battery of behavioral tests, including foot fault, postural flexing, and 
corner turn, and arrive at a combination score, as reported.4 All ani-
mals survived to the terminal end point.
RNA Isolation and Quantitative Reverse 
Transcription-Polymerase Chain Reaction
The RNA extraction and SYBR Green-based quantitative reverse 
transcription-polymerase chain reaction were performed as we 
described.3,4,28 The sequences of primers are listed in Table I in the 
online-only Data Supplement. The expression fold-change was cal-
culated using the delta-delta Ct method.
Primary Brain Glial Culture and Microglia  
Isolation
The cortical cultures were prepared as we described.4 After a total of 
14 to 21 days in culture, the microglia were harvested by shaking the 
co-cultures and plated at a density of 1.4×105 cells/mL.
Bone Marrow-Derived Macrophages Isolation
Bone marrow was harvested from 2- to 4-month-old mice and pro-
cessed as describe.29
Phagocytosis Assay for DN
We assessed phagocytosis of DNs as earlier reported.30 Briefly, DNs 
were generated using γ irradiation. DNs were added to the microglia 
or bone marrow-derived macrophage cultures at 50:1/DNs:microglia/
bone marrow-derived macrophage for 1.5 hours. Phagocytosed DNs 
were visualized using neuronal-specific class III β-Tuj1 (tubulin) anti-
body and the amount of the Tuj1+ neurons per phagocyte was analyzed 
on still microscope images with ZEN blue edition software (Zeiss).
RNA-Sequencing and Analysis for Microglia
Cultured microglia from Mac-RXR-α−/− and RXR-αLoxP mice were 
incubated with 0.5 μmol/L bexarotene or 0.1% DMSO for 24 hours. 
We used 2×106 cells for RNA extraction. RNA-sequencing, including 
library construction and data analysis, was performed by Novogene 
Inc. The clean reads were mapped to the reference genome using 
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Integrative Genomics Viewer. Differential expression analysis was 
performed using DESeq2 R package; Enrichment analysis, including 
gene ontology enrichment and Kyoto encyclopedia of genes and 
genomes pathway, was done using clusterProfiler software.
Statistical Analysis
All data are expressed as mean±SEM. All statistical analyses were 
performed using the GraphPad Prism 7 and InStat. Repeated-
measures 2-way ANOVA followed by Tukey post hoc test was used 
to evaluate differences among groups at different time points in be-
havioral tests. Two-way ANOVA followed by Tukey post hoc test 
was used to analyze data with 2 grouping variables. Remaining data 
were analyzed using 1-way ANOVA followed by Tukey post hoc test. 
Nonpaired t test was used when 2 groups are compared.
Results
Gene Profile of RXR-α-Deficient Microglia Suggest 
Altered Phagocytic and Reparative Functions
We have reported that PPAR-γ promotes phagocytic activities 
and reparative capacities of microglia,3,4 suggesting that RXR-α 
a transcriptional partner of PPAR-γ, may (co)regulate microglia’ 
contribution to brain repair after stroke. To probe this notion, we 
now performed gene profile analysis of microglia from condi-
tional RXR-α knockout mice (Mac-RXR-α−/−), with RXR-α de-
letion selectively targeting myeloid phagocytes (Figures I and II 
in the online-only Data Supplement), in presence or absence of 
RXR agonist, bexarotene. RXR-αLoxP mice were used as control.
First, the genome mapping results of RXR-α confirmed the 
successful deletion of RXR-α exon 4 in microglia from Mac-
RXR-α−/− mice (Figure IC in the online-only Data Supplement). 
Next, the analysis of differential gene expression showed limited 
differences in gene expression between microglia from Mac-
RXR-α−/− and RXR-αLoxP mice, with only a few differentially 
expressed genes (Figure 1A). However, after exposure to the 
bexarotene, RXR-αLoxP microglia showed a total of 386 differen-
tially expressed gene (Figure 1B), and this induction of gene ex-
pression by bexarotene was reduced (20 differentially expressed 
gene) in Mac-RXR-α−/− microglia (Figure 1C). Gene ontology 
enrichment analysis of RXR-αLoxP microglia showed that bex-
arotene enhanced signaling pathways included lipid transport 
and metabolism (Apoe, Abca1 [ATP-binding cassette, subfamily 
A], and Srebf2 [sterol regulatory element binding protein-2]), 
tissue repair, and importantly, phagocytosis (CD36, Axl [AXL 
tyrosine kinase], Mertk [mer tyrosine kinase], and Tgm2 [trans-
glutaminase 2]; Figure 1D). The extent of activation of these 
RXR-mediated signaling pathways by bexarotene was diminished 
in Mac-RXR-α−/− microglia. In addition, activation of RXR with 
bexarotene suppressed migration, proliferation, and leukocyte ac-
tivation pathways (cathepsin c, Cx3cr1, and CD86) in RXR-αLoxP 
microglia (Figure 1D). These results provide useful insights into 
the role of RXR activation in microglial phagocytic and repara-
tive processes. Furthermore, the results of Kyoto encyclopedia of 
genes and genomes pathway analysis showed that activation of 
RXR with bexarotene-enhanced PPAR:RXR signaling pathways 
(Figure III in the online-only Data Supplement), confirming the 
important role of PPAR in RXR signaling in microglia.
Loss of RXR-α Impairs Phagocytic Capacity of MΦ
The optimal brain remodeling and poststroke recovery 
necessitates effective removal of proinflammatory infarcted 
tissue from the affected brain, process that requires MΦ and 
could be regulated by RXR. Thus, our next step was to deter-
mine if RXR improves the phagocytic capacity of microglia 
and macrophages. We harvested the microglia and bone 
marrow-derived macrophages from Mac-RXR-α−/− mice 
and RXR-αLoxP and exposed them to mouse apoptotic neu-
rons (target of phagocytosis) to establish an index of phag-
ocytosis, based on the amount of internalized neurons per 
phagocyte (Figure 2). We found that, compared to control 
cells, the phagocytic capacity of Mac-RXR-α−/− microglia 
(Figure 3A and 3B) and macrophages (Figure 3C and 3D) 
were significantly compromised, confirming that RXR-α 
deficiency is detrimental for phagocytosis. In agreement 
with the promoting role of RXR, in a parallel experiment we 
showed that activation of RXR with bexarotene-augmented 
phagocytic efficacy of microglia and macrophages in an 
RXR-α-dependent fashion (Figure 3).
These results suggest that RXR-α in both microglia and 
macrophages is important for efficient phagocytosis.
In Ischemia-Affected Brain, Selective Deletion  
of RXR-α in MΦ Is Associated With Reduced  
Expression of Genes That Control Reparative  
Functions of Phagocytes
To probe the role of RXR in MΦ after ischemic stroke, we 
subjected Mac-RXR-α−/− mice and RXR-αLoxP (littermate con-
trol) mice to a transient MCA/CCA occlusion. By measuring 
the infarct volume at 3 days after stroke, we established that 
Mac-RXR-α−/− and the RXR-αLoxP mice have indistinguish-
able infarctions (8.98±3.19 versus 8.10±2.81 mm3 for Mac-
RXR-α−/− and RXR-αLoxP, respectively; P=0.78, n=6/group), 
suggesting that RXR-α in MΦ does not modulate suscepti-
bility to ischemia during the acute stages of injury.
However, MΦ are well-known for their reparative func-
tions, properties that are controlled by RXR and could be 
important during repair after stroke. Granulocytes express 
negligible levels of RXR-α31 (also Figure II in the online-only 
Data Supplement) and as such were not considered as factor 
contributing to the outcome in this study.
Thus, to gain more insight into this process, we performed 
the gene expression profiling in ischemia-affected hemisphere 
at 3 days after MCA/CCAo in Mac-RXR-α−/− and RXR-αLoxP 
mice. Since the important role of RXR-α in MΦ includes tran-
scriptional control of lipid metabolism and phagocytic path-
ways, we probed for genes reflecting these functions, including 
LPL (lipoprotein lipase), CD36, and CD206 (Figure 4). When 
compared to RXR-αLoxP, Mac-RXR-α−/− mice showed reduced 
expression of genes encoding for (1) growth factors that mod-
ulate reparative processes and tissue remodeling, for example, 
bFGF and VEGF (vascular endothelial growth factor) and (2) 
scavenger receptors that modulate phagocytosis, for example, 
CD36, CD163, CD206, CD204, and ABCA1, which are also 
regarded as biomarkers for a reparative phenotype of MΦ 
(Figure 4). One limitation of this experiment is that it does not 
selectively analyze MΦ but the whole brain. However, simi-
larities in gene expression profile between the cultured mi-
croglia and whole brain (eg, genes signifying phagocytosis) 
suggest strong contribution of MΦ toward whole-brain pro-
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in MΦ in modulating phagocytosis and reparative processes in 
the stroke-affected brain.
RXR-α in MΦ Assist in Recovery After  
Focal Cerebral Ischemia
As demonstrated above, RXR-α deficiency in MΦ does not 
affect acute ischemic damage. However, the gene profile anal-
yses and analysis of phagocytic activities, suggest that RXR-α 
in MΦ could promote the reparative phenotype of MΦ impor-
tant in long-term recovery after stroke.
Thus, to test this hypothesis, we subjected Mac-RXR-α−/− 
and RXR-αLoxP mice to MCA/CCAo and then monitored the 
animals’ neurological deficit over 28 days, the time neces-
sary to achieve infarcted tissue clearance. We found that the 
neurological deficit at 28 days was significantly worse in 
Mac-RXR-α−/−, as compared to RXR-αLoxP mice (Figure 5A 
and 5B), signifying a beneficial role of MΦ RXR-α during 
the recovery process. Responses were similar for male and 
females (Figure IV in the online-only Data Supplement). 
After completing the behavioral assessment at day 28, we also 
measured brain atrophy (missing tissue) volume and estab-
lished that Mac-RXR-α−/− had larger atrophy than the RXR-
αLoxP mice (Figure 5C; gray versus black), especially among 
male mice (Figure V in the online-only Data Supplement), 
suggesting that RXR-α in MΦ is needed to limit matura-
tion/progression of brain atrophy. To emphasize the rele-
vance of brain atrophy volume, at the end of the experiment 
(day 28), we revealed a positive correlation between the at-
rophy volume and neurological deficit (which was similar for 
both genotypes; Figure 5D). This provided new and impor-
tant information: histological damage at 4 weeks accurately 
predicts functional outcome. Also, these results suggest that 
approaches aimed at activating RXR-α may represent a target 
for improving stroke recovery.
Figure 1. Diminished reparative phenotype of microglia from Mac-RXRα−/−mice; RNA-seq analysis. A, Mac-RXR-α−/− vehicle compared to RXR-αLoxP vehicle 
with 4 differentially expressed genes (DEGs); (B) RXR-αLoxP BEX (bexarotene) compared to RXR-αLoxP vehicle with 386 DEGs, and (C) Mac-RXR-α−/− BEX com-
pared to Mac-RXR-α−/− vehicle with 20 DEGs. D, Gene ontology enrichment analysis showed pathways that were significantly upregulated and downregu-
lated by RXR (retinoic X receptor) agonist BEX in RXR-αLoxP microglia. Primary cultured microglia from Mac-RXR-α−/− and RXR-αLoxP mice were incubated with 
0.5 μmol/L BEX or vehicle control (0.1% dimethyl sulfoxide [DMSO]) for 24 h before RNA isolation. Each RNA sample was extracted from 2×106 cells. Three 
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Bexarotene Improves Poststroke Recovery After  
Focal Cerebral Ischemia With a 1-Day  
Therapeutic Window
Our next experiment investigated RXR-α as a therapeutic 
target for poststroke recovery. Since our in vivo experiment 
with Mac-RXR-α−/− suggests that RXR-α plays a role during 
the postacute recovery process, we tested the therapeutic rele-
vance of RXR activation to poststroke recovery. We used clin-
ically translational bexarotene to activate RXR. We subjected 
Mac-RXR-α−/− and the control mice to MCA/CCAo and then 
administered bexarotene at 24 hours after stroke and then 
daily for 7 days. We found that control animals receiving bex-
arotene showed the most robust neurological recovery, with 
a significant improvement seen at day 14 after the stroke that 
persisted until day 28, the end of the experiment (Figure 5A; 
red versus black lines). The beneficial effects of bexarotene on 
recovery were not detected on day 3 and 7, suggesting again 
that bexarotene acts through mediating processes involved in 
secondary injury or repair. Notably, we did not see beneficial 
effects of bexarotene on poststroke recovery in Mac-RXR-α−/− 
mice (Figure 5A and 5B; blue versus gray lines), suggest-
ing that at least in part, the role of bexarotene in recovery is 
through modulation of RXR-α activity in MΦ.
After concluding behavioral assessments (day 28), we 
measured the brain atrophy to determine the tissue loss at the 
site of ischemic injury. In agreement with the neurological 
assessment, bexarotene-treated control mice demonstrated 
reduced brain atrophy volumes (Figure 5C; red versus black). 
The beneficial effect of bexarotene on brain tissue preserva-
tion was lost in Mac-RXR-α−/− mice.
We did not detect major differences in any measured 
responses between male and female mice (Figures IV and V 
in the online-only Data Supplement).
Discussion
Our hypothesis was that MΦ-mediated brain cleanup (eg, 
phagocytosis-mediated removal of dead tissue) may play essen-
tial role in poststroke recovery. To test this hypothesis, we took 
advantage of a well-established role of RXR-α as key regulator 
of phagocytic activities of myeloid MΦ and the use of lysozyme 
M-Cre to delete RXR-α in these cells. The neutrophils express 
RXR-α at the negligible level31 (and Figure II in the online-only 
Data Supplement) and as such were not considered as contrib-
utor to the process. Using in vitro phagocytosis assay, we de-
termined that microglia and macrophages respond similarly to 
RXR modulation, thus we did not differentiate between these 
cells, regarding their contribution to poststroke recover. Using 
reversible ischemia model, a model that in the era of thromboly-
sis and thrombectomy has major translational value,32 we estab-
lished that Mac-RXR-α−/− mice have worse poststroke recovery, 
as compared to control mice, despite similar level of the initial 
damage (up to 3 days post-ictus), based on the infarct volume 
and neurological deficit assessment. In agreement with a benefi-
cial role for RXR during the poststroke recovery phase, repetitive 
activation of RXR with the clinically relevant RXR-activating 
agent bexarotene, initiated as late as 24 hours after the stroke 
onset, improved the recovery rate, as assessed with validated 
sensory-motor tests.4 Our in vitro functional data with MΦ in 
culture indicate that one of the important roles RXR-α plays in 
MΦ is to enhance phagocytosis,8,17 a process that is responsible 
Figure 2. Microglia phagocytose apoptotic 
neurons. Representative micrograph illustrat-
ing primary cultured microglia (CD68+ cells/
green) phagocytosing apoptotic neurons (neu-
ronal tubulin 1/Tuj1+/red), used for establish-
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for brain cleanup and inflammation resolution through removal 
of damage-associated cellular debris. Also, our RNA-sequencing 
data suggest the importance of RXR-α in phagocytic and repar-
ative phenotype activation. Although the phenotypic difference 
between RXR-α-deficient and proficient microglia is limited in 
the absence of stimulus, activating RXR with bexarotene signif-
icantly increases expression of genes involved in lipid transport 
and metabolism, tissue remodeling, and phagocytosis in RXR-
α-proficient (and not deficient) MΦ. All of these pathways are 
essential for cleanup and repair processes in brain tissue after 
stroke. Furthermore, the PPAR-γ signaling pathway is upregu-
lated in RXR-α-proficient but not RXR-α-deficient microglia 
after exposure to bexarotene, suggesting an eminent role for 
PPAR-γ in RXR-α transcriptional regulation. We and others 
have previously demonstrated that MΦ-mediated cleanup is, in 
part, under the control of PPAR-γ, a transcriptional partner of 
RXR, which in MΦ regulates the expression of several scav-
enger receptors, molecules that are critical for debris clearance 
during phagocytic engulfment.17,33 Examples include CD36, 
Axl, and Mertk, proteins that we and others have implicated in 
the postintracerebral hemorrhage cleanup process.3,34 Thus, one 
possible scenario is that RXR-mediated prophagocytic effects 
are achieved through activation of transcriptional activities of the 
RXR:PPAR-γ complex through direct RXR activation. Indeed, 
this cooperative interaction appears to be the likely scenario. By 
using primary rat microglia (data not included), we documented 
that activation of RXR with bexarotene effectively augmented 
PPAR-γ agonist (rosiglitazone)-induced phagocytic activity. 
In a more direct experiment, we showed that PPAR-γ antago-
nist could reverse bexarotene-augmented microglia-mediated 
Figure 3. Loss of RXR (retinoic X receptor)-α in microglia or macrophages impairs phagocytosis. The primary microglia (A and B) in culture or bone marrow-
derived macrophages (BMM; C and D) were harvested from RXR-αLoxP and Mac-RXR-α−/− pup brains and treated with 0.1% dimethyl sulfoxide (DMSO; 
vehicle) or bexarotene (BEX, 0.5 μmol/L). Twenty-four hours later, cells were exposed to mouse apoptotic neurons. Phagocytic index was determined at 
1.5 h by measuring the amount of engulfed apoptotic neurons per individual phagocyte, based on Tuj1+ pixel count in each analyzed cell. The boundary of 
phagocyte was establish using CD68 immuno-labeling. Nuclei were stained with 4′,6-diamidino-2-phenylindole (blue). B and D, Bar graphs demonstrating 
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phagocytosis (data not included). Finally, our targeted analyses 
of the gene expression profile in the ischemia-affected brain tis-
sue from Mac-RXRα−/− mice, suggest that the loss of RXR-α in 
MΦ coincided with the reduced expression of prototypic PPAR-
γ-regulated genes, such as lipoprotein lipase, CD36, and cata-
lase, as well as PPAR-γ itself. Collectively, this data indicate that 
the inhibition (knockout) or stimulation (bexarotene) of RXR in 
microglia is mirrored by similar responses of PPAR-γ, suggest-
ing that under our experimental conditions, the activity of RXR 
in MΦ is effectively coupled to PPAR-γ.
Various cellular mechanisms are engaged in the regulation 
of phagocytic/endocytic functions conducted by MΦ. One such 
essential mechanism, especially in relation to damage associ-
ated with the septic form of inflammation such as that caused 
by ischemia-induced damage, is through expression of var-
ious scavenger receptors. These membrane-associated proteins 
are intrinsic to various forms of MΦ and play key roles in the 
postinjury tissue cleanup and repair.35,36 We established here 
that the RXR-α deficiency in MΦ is associated with the reduced 
expression of several scavenger receptors in the brains of mice 
subjected to MCA/CCAo. These changes, as measured 3 days 
after the stroke, included reduced expression of CD36 (the de-
fining member of class B scavenger receptors with a well-es-
tablished role in efferocytosis), CD163 (scavenger receptor for 
hemoglobin:haptoglobin complexes and other cell degradation 
products37,38), CD206 (mannose receptor that is involved in en-
gulfment of several mannose-bearing serum glycoproteins39), 
and CD204 (SR-A/class A scavenger receptor involved in var-
ious phagocytic/endocytic functions40). It has to be emphasized 
that these gene expression changes were unlikely related to the 
extent of initial ischemic damage, as Mac-RXR-α−/− and the 
control mice demonstrated indistinguishable infarct volume 
and behavioral deficit at the time point when gene analysis was 
performed. It has to be independently noted that the above scav-
enger receptors are also often recognized as biomarkers for the 
reparative phenotype of MΦ. This is often referred to as the M2 
phenotype, MΦ with stronger phagocytic capabilities, antioxi-
dative activities, and able to more effectively generate anti-in-
flammatory cytokines and trophic factors.13
Figure 4. In ischemia-affected brain, RXR (retinoic X receptor)-α deletion 
in microglia/macrophages (MΦ) leads to reduced expression of genes 
that signify reparative functions of microglia. Gene expression profile (by 
quantitative reverse transcription-polymerase chain reaction [RT-qPCR]) 
for the indicated genes in ischemia-affected ipsilateral cortices of RXR-
αLoxP and Mac-RXR-α−/− mice, 3 d after middle cerebral artery (MCA)/
CCAo. Gene expression fold-change was calculated using delta-delta Ct 
method with RXR-αLoxP mice as baseline and GAPDH as reference gene. 




Figure 5. Neurological deficit outcomes and brain atrophy volumes 28 d after middle cerebral artery (MCA)/common carotid artery occlusion (CCAo). The 
Mac-RXR-α−/− and RXR-αLoxP mice were subjected to 60 min of MCA/CCAo. Bexarotene (BEX), 5 mg/kg, or vehicle was injected intraperitoneally, starting at 
24 h after MCA/CCAo and then daily for 7 d. The composite neurological deficit scores (Grand NDS) (A), and the individual NDS including postural flexing, 
foot fault, and corner turning (B) on day 1 through day 28 are demonstrated. Data are expressed as mean±SEM (n=10/group). **P<0.01. Repeated measure 
2-way ANOVA followed by pairwise comparison. C, The brain atrophy volume at the site of ischemic injury at day 28 was measured. Data are expressed as 
mean±SEM (n=18 in each vehicle group and n=10 in each BEX group). *P<0.05, **P<0.01. Two-way ANOVA followed by pairwise comparison. D, Correlations 
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A reason for why the atrophy volume at 4 weeks after 
stroke was larger in Mac-RXR-α−/− mice as compared to 
the control mice cannot be clearly deduced from the ex-
perimental data collected in this study. We know that the 
initial stroke-induced injury was similar in the control and 
Mac-RXR-α−/− mice. Thus, it is justified to assume that 
the differences in lesion size could be due to pathogenic 
processes that took place at some later stages of ischemic 
lesion maturation. Also, since these changes occurred as a 
result of modification primarily limited to MΦ, we assume 
that at least one of the MΦ functions that are under control 
of RXR is causally related to differences in the ischemic 
outcome in these animals. As we discussed earlier, one 
key function of MΦ is to conduct phagocytosis-mediated 
cleanup to achieve a better and faster elimination of dying 
cells and cellular debris, the main source of cytotoxicity 
and deleterious inflammation. In agreement with the ex-
isting data,7,8 our in vitro experiments suggest that RXR 
indeed plays an important role in optimizing the phagocytic 
function of MΦ, and as such RXR activation (eg, with bex-
arotene) after stroke could enhance the cleanup and reduce 
the injury to the brain tissue caused by toxic byproducts of 
ischemic injury. Finally, since the behavioral deficit across 
the genotypes showed a positive correlation with the brain 
atrophy volume, we think that it is unlikely that the sole 
neuronal plasticity (independent of the total lesion size) 
within the perilesional brain tissue could account for the 
behavioral improvement. This once again suggests that the 
cleanup process could account for a key mechanism associ-
ated with functional outcome.
In conclusion, we propose that RXR could represent an 
attractive and clinically relevant target for improving post-
stroke recovery through modification of MΦ.
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